SCHEMBL3484567

SCHEMBL3484567

Cc1cc(CCC(CO)Cc2ccc(C(=O)O)cc2)ccc1C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 2/20 0.41
RARB P10826 2/20 0.40
GRIN2D O15399 1/20 0.39
GRIN2A Q12879 1/20 0.39
GRIN2B Q13224 1/20 0.39
GRIN2C Q14957 1/20 0.39
ACE2 Q9BYF1 1/20 0.39
ANPEP P15144 1/20 0.38
ENPEP Q07075 1/20 0.38
TSHR P16473 1/20 0.38
ALDH1A1 P00352 2/20 0.38
FOLH1 Q04609 5/20 0.38
TDP1 Q9NUW8 2/20 0.36
RXRA P19793 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36
POLB P06746 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3484562 0.95 RARB (0.43) NR1H4RARBGRIN2DGRIN2AGRIN2B
SCHEMBL3485094 0.86 NR1H4 (0.41) NR1H4RARBGRIN2DGRIN2AGRIN2B
SCHEMBL2489653 0.84 ANPEP (0.47) RARBANPEPENPEPTSHRALDH1A1
SCHEMBL3484856 0.81 NR1H4 (0.41) NR1H4RARBGRIN2DGRIN2AGRIN2B
SCHEMBL4668519 0.78 TSHR (0.39) NR1H4RARBGRIN2DGRIN2AGRIN2B
SCHEMBL17586550 0.77 GRIN2D (0.50) NR1H4RARBGRIN2DGRIN2AGRIN2B
SCHEMBL2160396 0.76 ALDH1A1 (0.48) RARBANPEPENPEPTSHRALDH1A1
SCHEMBL3484851 0.75 RARB (0.42) NR1H4RARBGRIN2DGRIN2AGRIN2B
SCHEMBL23927631 0.75 RARB (0.51) NR1H4RARBALDH1A1RXRAKDM4E
SCHEMBL2567753 0.75 RARB (0.46) NR1H4RARBGRIN2DGRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8609727-B2 Dicarboxylic acid derivatives and their use BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-12-17 US disclosed
US-20100029772-A1 Dicarboxylic Acid Derivatives and their Use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029772-A1 Dicarboxylic Acid Derivatives and their Use PC, SLC25A1, GOT2 NR1H4 852/4885RARB 1092/4885GRIN2D 1367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.